跳至主要内容
临床试验/JPRN-jRCTs032200108
JPRN-jRCTs032200108已完成1 期

Clinical research to confirm the safety of bone regenerationpromoting materials based on type 1 collagen - Synthetic bone graft substitute transplantation for the socket preservation

Tobita Morikuni0 个研究点目标入组 0 人开始时间: 2020年9月7日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Patients who perform tooth extraction on the premise of the dental implant treatment

排除标准

  • -Active generalized periodontal disease; evident periapical radiolucencies or abscesses
  • -autoimmune disorders; taking or having a history of bisphosphonate medications or Denosumab (history of MRONJ (medication-related osteonecrosis of the jaw)/BRONJ (bisphosphonate-related osteonecrosis of the jaw))
  • -Current taking methotrexate(MTX) or steroids.
  • -Congenital or metabolic bone disorders; or uncontrolled diabetes.
  • -Current or former smoker or user of chewing tobacco or nicotine-containing products
  • -Females who are pregnant, breastfeeding, or are planning to conceive during their enrollment in the clinical investigation.
  • -History of any severe allergic or anaphylactic reactions to collagen or gelatin, or current sensitivity to collagen or gelatin.
  • -Have a history of complicate malignant tumor.

研究者

发起方
Tobita Morikuni

相似试验